NCT05903469

Brief Summary

In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

3.4 years

First QC Date

June 6, 2023

Last Update Submit

May 23, 2025

Conditions

Keywords

Implicit association testSuicidePrevention, Suicidesuicide risk factor

Outcome Measures

Primary Outcomes (1)

  • Variation of IAT score betwenn the 3 groups

    IAT is Implicit Attitude Test The IAT is a brief computer-administered test that uses people's reaction times when classifying semantic stimuli to measure the automatic mental associations they hold about various topics, in this case, life and death/suicide. The death/suicide IAT will be administered and scored in keeping with standard IAT procedures. Response latencies for all trials were recorded and analyzed using the standard IAT scoring algorithm.

    one year

Study Arms (3)

Patient with explicit suicidal ideation and suicide attempt

EXPERIMENTAL
Other: Implicit Attitude Test

Patient with explicit suicidal ideation without suicide attempt

EXPERIMENTAL
Other: Implicit Attitude Test

Patient without explicit suicidal ideation

ACTIVE COMPARATOR
Other: Implicit Attitude Test

Interventions

The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer. The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.

Patient with explicit suicidal ideation and suicide attemptPatient with explicit suicidal ideation without suicide attemptPatient without explicit suicidal ideation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Person presenting to emergencies for psychiatric reasons
  • Adult person
  • Free and informed consent signed
  • Person speaking and writing French fluently

You may not qualify if:

  • Neurological disorders or major cognitive deterioration: presence of confusion
  • Acute psychotic decompensation
  • Troubled acute behavior
  • Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment
  • Adult under protective measure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

RECRUITING

MeSH Terms

Conditions

SuicideSuicide Prevention

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2023

First Posted

June 15, 2023

Study Start

June 28, 2022

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

May 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations